Companies agilon health
agilon health (AGL): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me agilon health’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers6th pct.Of 16 peer CEOs
CEO pay, last three years
- $7,136,122FY2024
- $5,610,878FY2025
CEO total pay was $5,610,878 in fiscal 2025, down from $7,136,122 in fiscal 2024.
FY2025: salary $625,000 · bonus $0 · stock awards $2,950,003 · option awards $1,750,000
Executives and directors
Benjamin Shaker · CEOJeffrey Schwaneke · CEOSteven Sell · ExecutiveDenise Zamore · General CounselGirish Venkatachaliah · CTODiana L. McKenzie · Independent DirectorKaren McLoughlin · Independent DirectorRavi Sachdev · DirectorRon Williams · DirectorSharad Mansukani, M.D · Independent DirectorSilvana Battaglia · Independent DirectorWilliam Wulf, M.D · Independent Director
Frequently asked questions
Who was the highest-paid executive at agilon health in fiscal 2025?
As disclosed, Steven Sell (Former Chief Executive Officer and President) was the highest-paid executive at agilon health in fiscal 2025, with total compensation of $7,278,387.
How does agilon health's chief executive pay compare to its disclosed peer group?
As disclosed, Jeffrey Schwaneke's total compensation ranked at the 6th percentile of agilon health's disclosed peer group.
What is agilon health's CEO-to-median employee pay ratio?
As disclosed, agilon health's CEO-to-median employee pay ratio was 82:1.
How did shareholders vote on agilon health's executive compensation?
As disclosed, 94.7% of shareholders supported agilon health's executive compensation in the latest say-on-pay vote.
How much does agilon health spend in total on board compensation for fiscal 2025?
As disclosed, agilon health reported total board compensation of $1,527,506 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Steven Sell | $431,507 | $0 | $4,050,004 | $2,250,001 | $0 | $0 | $546,875 | $7,278,387 |
| Former Chief Executive Officer and President | ||||||||
| Jeffrey Schwaneke | 625,000 | 0 | 2,950,003 | 1,750,000 | 271,875 | 0 | 14,000 | 5,610,878 |
| Chief Financial Officer and Interim Co-Principal Executive Officer | ||||||||
| Benjamin Shaker | 450,000 | 0 | 2,950,003 | 1,750,000 | 193,545 | 0 | 14,000 | 5,357,548 |
| Chief Markets Officer and Interim Co-Principal Executive Officer | ||||||||
| Denise Zamore | 425,000 | 0 | 1,500,008 | 1,000,002 | 184,408 | 0 | 14,000 | 3,123,418 |
| Chief Legal Officer and Corporate Secretary | ||||||||
| Girish Venkatachaliah | 425,000 | 0 | 937,506 | 500,001 | 184,875 | 0 | 8,704 | 2,056,086 |
| Chief Technology Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Steven Sell | $7,278,387 | $5,416,043 | $5,267,036 | ↑ +1,862,344 |
| Jeffrey Schwaneke | 5,610,878 | 7,136,122 | — | ↓ −1,525,244 |
| Benjamin Shaker | 5,357,548 | 4,102,777 | 2,930,218 | ↑ +1,254,771 |
| Denise Zamore | 3,123,418 | — | — | — |
| Girish Venkatachaliah | 2,056,086 | 2,560,893 | 2,880,218 | ↓ −504,807 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Committee continued to evaluate and refine the Company's compensation programs to ensure alignment with evolving strategic priorities and to reinforce a disciplined approach to pay.
| CEO STI target (% of salary) | 75% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Semler Brossy |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Girish Venkatachaliah | RSU | 2025-04-01 | — | — | 4,902 | — | $500,004 |
| Girish Venkatachaliah | PSU | 2025-04-01 | 4,289 | 4,289 | — | 17,156 | 437,502 |
| Denise Zamore | RSU | 2025-04-01 | — | — | 9,803 | — | 1,000,004 |
| Denise Zamore | PSU | 2025-04-01 | 4,902 | 4,902 | — | 19,608 | 500,004 |
| Benjamin Shaker | RSU | 2025-04-01 | — | — | 17,156 | — | 1,750,002 |
| Jeffrey Schwaneke | OPTION | 2025-04-01 | — | — | 26,923 | — | 1,750,000 |
| Benjamin Shaker | OPTION | 2025-04-01 | — | — | 26,923 | — | 1,750,000 |
| Girish Venkatachaliah | OPTION | 2025-04-01 | — | — | 7,692 | — | 500,001 |
| Steven Sell | OPTION | 2025-04-01 | — | — | 34,615 | — | 2,250,001 |
| Steven Sell | PSU | 2025-04-01 | 17,647 | 17,647 | — | 70,588 | 1,800,002 |
| Jeffrey Schwaneke | PSU | 2025-04-01 | 11,764 | 11,764 | — | 47,056 | 1,200,001 |
| Steven Sell | RSU | 2025-04-01 | — | — | 22,058 | — | 2,250,002 |
| Benjamin Shaker | PSU | 2025-04-01 | 11,764 | 11,764 | — | 47,056 | 1,200,001 |
| Jeffrey Schwaneke | RSU | 2025-04-01 | — | — | 17,156 | — | 1,750,002 |
| Denise Zamore | OPTION | 2025-04-01 | — | — | 15,384 | — | 1,000,002 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Girish Venkatachaliah | $500,004 | $437,502 | $500,001 | 30.4% |
| Denise Zamore | 1,000,004 | 500,004 | 1,000,002 | 20.0% |
| Benjamin Shaker | 1,750,002 | 1,200,001 | 1,750,000 | 25.5% |
| Jeffrey Schwaneke | 1,750,002 | 1,200,001 | 1,750,000 | 25.5% |
| Steven Sell | 2,250,002 | 1,800,002 | 2,250,001 | 28.6% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Girish Venkatachaliah | RSU | 108 | — | $1,860 |
| Denise Zamore | RSU | 117 | — | 2,015 |
| Denise Zamore | RSU | 132 | — | 2,274 |
| Benjamin Shaker | RSU | 135 | — | 2,325 |
| Benjamin Shaker | RSU | 439 | — | 7,562 |
| Girish Venkatachaliah | RSU | 439 | — | 7,562 |
| Denise Zamore | PSU | 1,666 | — | 28,697 |
| Denise Zamore | RSU | 2,102 | — | 36,207 |
| Denise Zamore | RSU | 3,095 | — | 53,311 |
| Girish Venkatachaliah | RSU | 3,363 | — | 57,928 |
| Denise Zamore | Option | 3,459 | 111.5 | — |
| Jeffrey Schwaneke | RSU | 3,960 | — | 68,211 |
| Girish Venkatachaliah | PSU | 4,289 | — | 73,878 |
| Girish Venkatachaliah | RSU | 4,902 | — | 84,437 |
| Denise Zamore | PSU | 4,902 | — | 84,437 |
| Girish Venkatachaliah | Option | 5,535 | 111.5 | — |
| Denise Zamore | PSU | 5,605 | — | 96,546 |
| Benjamin Shaker | RSU | 5,886 | — | 101,386 |
| Jeffrey Schwaneke | PSU | 6,033 | — | 103,918 |
| Jeffrey Schwaneke | Option | 7,172 | 151.75 | — |
| Girish Venkatachaliah | Option | 7,692 | 102 | — |
| Girish Venkatachaliah | PSU | 8,968 | — | 154,474 |
| Benjamin Shaker | Option | 9,687 | 111.5 | — |
| Denise Zamore | RSU | 9,803 | — | 168,857 |
| Jeffrey Schwaneke | RSU | 10,055 | — | 173,197 |
| Jeffrey Schwaneke | PSU | 10,558 | — | 181,862 |
| Jeffrey Schwaneke | PSU | 11,764 | — | 202,635 |
| Benjamin Shaker | PSU | 11,764 | — | 202,635 |
| Denise Zamore | Option | 15,384 | 102 | — |
| Benjamin Shaker | PSU | 15,695 | — | 270,346 |
| Jeffrey Schwaneke | RSU | 17,156 | — | 295,512 |
| Benjamin Shaker | RSU | 17,156 | — | 295,512 |
| Jeffrey Schwaneke | Option | 26,923 | 102 | — |
| Benjamin Shaker | Option | 26,923 | 102 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Karen McLoughlinIndependent · Audit (Chair) · Compensation and Human Capital · Nominating & Governance | $95,000 | $185,001 | $0 | $0 | $0 | $280,001 |
| William Wulf, M.DIndependent · Audit · Nominating & Governance · Compliance and Quality (Chair) | 85,000 | 185,001 | 0 | 0 | 0 | 270,001 |
| Diana L. McKenzieIndependent · Audit · Compensation and Human Capital (Chair) | 85,000 | 185,001 | 0 | 0 | 0 | 270,001 |
| Sharad Mansukani, M.DIndependent · Nominating & Governance (Chair) · Compliance and Quality | 82,500 | 185,001 | 0 | 0 | 0 | 267,501 |
| Silvana BattagliaIndependent · Compensation and Human Capital | 70,000 | 185,001 | 0 | 0 | 0 | 255,001 |
| Ron WilliamsEmployee director · Nominating/Governance | 0 | 185,001 | 0 | 0 | 0 | 185,001 |
| Ravi SachdevNot independent · Compliance and Quality | 0 | 0 | 0 | 0 | 0 | 0 |
| Steven J. SellNot independent | 0 | 0 | 0 | 0 | 0 | 0 |
| Jeffrey A. SchwanekeNot independent | — | — | 0 | 0 | 0 | — |
Board fee structure and ownership guideline
| Annual cash retainer | $70,000 |
|---|---|
| Annual equity retainer | $185,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 15,000 / 15,000 |
| Stock ownership guideline | Non-Employee Directors* 5x Annual Board Cash Retainer |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $417,500 |
| Equity awards (grant-date value) | $1,110,006 |
| All other compensation | $0 |
| Total cost of the board | $1,527,506 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names agilon health as a peer
Companies that benchmark against AGL
7 companies name AGL as a compensation peer
The list of companies that name AGL as a peer is temporarily unavailable — recheck shortly.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
ASTH Astrana Health, Inc.DVA DaVita Inc.DOCS Doximity, Inc.EVH Evolent Health, Inc.RCM R1 RCM Inc.PGNY Progyny, Inc.ALHC Alignment Healthcare, Inc.PRVA Privia Health Group, Inc.CERT Certara, Inc.GDRX GoodRx Holdings, Inc.GH Guardant Health, Inc.HQY HealthEquity, Inc.LFST LifeStance Health Group, Inc.DGX Quest Diagnostics, Inc.TDOC Teladoc Health, Inc.VEEV Veeva Systems, Inc.
Peer reciprocity
Of the companies agilon health names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Astrana Health, Inc. (ASTH)— DaVita Inc. (DVA)54— Doximity, Inc. (DOCS)55✓ Evolent Health, Inc. (EVH)56— R1 RCM Inc. (RCM)57— Progyny, Inc. (PGNY)58✓ Alignment Healthcare, Inc. (ALHC)59✓ Privia Health Group, Inc. (PRVA)60— Certara, Inc. (CERT)61— GoodRx Holdings, Inc. (GDRX)62— Guardant Health, Inc. (GH)63— HealthEquity, Inc. (HQY)64— LifeStance Health Group, Inc. (LFST)65— Quest Diagnostics, Inc. (DGX)66✓ Teladoc Health, Inc. (TDOC)67— Veeva Systems, Inc. (VEEV)68
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including agilon health.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | GoodRx Holdings, Inc. | 2025 | Wendy Barnes | $825,000 | $10,921,182 | $9,000,000 | $0 | $23,367,483 |
| 2 | Doximity, Inc. | 2026 | Jeff Tangney | 627,000 | 18,955,899 | 0 | 0 | 19,586,169 |
| 3 | DaVita Inc. | 2025 | Javier Rodriguez | 1,500,000 | 11,442,481 | 2,699,982 | 2,089,491 | 18,210,597 |
| 4 | Quest Diagnostics, Inc. | 2025 | James Davis | 1,250,000 | 8,762,861 | 2,999,873 | 2,205,844 | 15,498,479 |
| 5 | Astrana Health, Inc. | 2025 | Brandon Sim | 850,000 | 11,999,980 | 0 | 2,059,125 | 14,930,231 |
| 6 | Evolent Health, Inc. | 2025 | Seth Blackley | 867,068 | 12,699,086 | 0 | 0 | 14,240,154 |
| 7 | R1 RCM Inc. | 2023 | Lee Rivas | 900,000 | 12,240,021 | 0 | 1,015,200 | 14,159,376 |
| 8 | HealthEquity, Inc. | 2026 | Scott Cutler | 775,000 | 12,038,563 | 0 | 767,250 | 13,582,105 |
| 9 | Alignment Healthcare, Inc. | 2025 | John Kao | 833,654 | 8,500,014 | 0 | 1,944,495 | 11,278,583 |
| 10 | Teladoc Health, Inc. | 2025 | Charles Divita, III | 800,000 | 9,699,996 | 0 | 584,000 | 11,202,996 |
| 11 | Privia Health Group, Inc. | 2025 | Parth Mehrotra | 650,000 | 8,588,373 | 0 | 1,218,750 | 10,472,698 |
| 12 | Guardant Health, Inc. | 2025 | AmirAli Talasaz | 1 | 8,647,709 | 0 | 0 | 8,661,227 |
| 13 | Progyny, Inc. | 2025 | Peter Anevski | 870,000 | 3,499,980 | 2,099,995 | 736,890 | 7,220,612 |
| 14 | LifeStance Health Group, Inc. | 2025 | David Bourdon | 657,692 | 5,257,623 | 0 | 716,065 | 6,645,380 |
| 15 | Certara, Inc. | 2025 | William Feehery | 795,675 | 4,927,502 | 0 | 747,935 | 6,491,387 |
| 16 | agilon health | 2025 | Jeffrey Schwaneke | 625,000 | 2,950,003 | 1,750,000 | 271,875 | 5,610,878 |
| 17 | Veeva Systems, Inc. | 2026 | Peter Gassner | 470,833 | 0 | 0 | 0 | 470,833 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| agilon health | 58% | not disclosed | No | Semler Brossy |
| Alignment Healthcare, Inc. | 200% | not disclosed | No | FW Cook |
| Astrana Health, Inc. | 193.8% | PSU 67 · RSU 33 | No | Pearl Meyer |
| Certara, Inc. | 94% | PSU 60 · RSU 40 | Yes — annualized total stockholder return (ATSR) | Meridian Compensation Partners |
| DaVita Inc. | 93% | PSU 60 · RSU 20 · Options 20 | Yes — Relative TSR v. S&P Health Care Services Select Industry Index | Compensia |
| Doximity, Inc. | not disclosed | not disclosed | No | Aon plc (Human Capital Solutions Practice) |
| Evolent Health, Inc. | 75% | PSU 70 · RSU 30 | No | Exequity |
| GoodRx Holdings, Inc. | not disclosed | not disclosed | not disclosed | Pay Governance |
| Guardant Health, Inc. | 140% | PSU 50 · RSU 50 · Option 35 | No | Aon |
| HealthEquity, Inc. | 99% | PSU 60 · RSU 40 | Yes | Semler Brossy |
| LifeStance Health Group, Inc. | not disclosed | not disclosed | not disclosed | Pay Governance |
| Privia Health Group, Inc. | 150% | PSU 60 · RSU 40 | No | Korn Ferry (through September 2025), WTW (starting September 2025) |
| Progyny, Inc. | 85% | RSU 40 · Options 30 · PSU 30 | No | Semler Brossy |
| Quest Diagnostics, Inc. | 113.9% | PSU 50 · RSU 25 · Options 25 | Yes — Relative TSR | Semler Brossy |
| R1 RCM Inc. | 94% | PSU 75 · RSU 25 | No | SullivanCotter |
| Teladoc Health, Inc. | 73% | RSU 50 · PSU 50 | No | Aon |
| Veeva Systems, Inc. | not disclosed | Options 100 | not disclosed | Compensia |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-02 | 11,228,258 | 627,870 | 8,624 | 94.7% | Passed |
| 2025 | 2025-05-28 | 286,771,841 | 83,515,983 | 94,016 | 77.45% | Passed |
| 2024 | 2024-05-29 | 318,678,236 | 66,152,444 | 96,776 | 82.81% | Passed |
| 2023 | 2023-05-24 | 333,822,301 | 58,625,836 | 76,693 | 85.06% | Passed |
| 2022 | 2022-05-24 | 377,553,551 | 1,242,310 | 370,474 | 99.67% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-06-02 | 94.7%a |
| 2025 | 2025-05-28 | 77.45%b |
| 2024 | 2024-05-29 | 82.81%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Voting standard not stated in the filing.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 82 : 1 |
|---|---|
| CEO total compensation | $5,610,878 |
| Median employee compensation | $68,133 |
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (68 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Steven Sell. DEF 14A, filed 2026-04-22. Section “Compensation Table”. As printed: 7,278,387. View filing ↗
- Section 01, Jeffrey Schwaneke. DEF 14A, filed 2026-04-22. Section “Compensation Table”. As printed: 5,610,878. View filing ↗
- Section 01, Benjamin Shaker. DEF 14A, filed 2026-04-22. Section “Compensation Table”. As printed: 5,357,548. View filing ↗
- Section 01, Denise Zamore. DEF 14A, filed 2026-04-22. Section “Compensation Table”. As printed: 3,123,418. View filing ↗
- Section 01, Girish Venkatachaliah. DEF 14A, filed 2026-04-22. Section “Compensation Table”. As printed: 2,056,086. View filing ↗
- Section 03, Girish Venkatachaliah RSU. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Girish Venkatachaliah PSU. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Denise Zamore RSU. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Denise Zamore PSU. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Benjamin Shaker RSU. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Jeffrey Schwaneke OPTION. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Benjamin Shaker OPTION. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Girish Venkatachaliah OPTION. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Steven Sell OPTION. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Steven Sell PSU. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Jeffrey Schwaneke PSU. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Steven Sell RSU. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Benjamin Shaker PSU. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Jeffrey Schwaneke RSU. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Denise Zamore OPTION. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-04-22. Section “CEO Pay Ratio”. As printed: 82 : 1. View filing ↗
- Section 08, Karen McLoughlin. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: 280,001. View filing ↗
- Section 08, William Wulf, M.D. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: 270,001. View filing ↗
- Section 08, Diana L. McKenzie. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: 270,001. View filing ↗
- Section 08, Sharad Mansukani, M.D. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: 267,501. View filing ↗
- Section 08, Silvana Battaglia. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: 255,001. View filing ↗
- Section 08, Ron Williams. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: 185,001. View filing ↗
- Section 08, Ravi Sachdev. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Steven J. Sell. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Jeffrey A. Schwaneke. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: —. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-06-03. Item 5.07 · say-on-pay result. As reported: 94.7% (votes for as printed: 11,228,258). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-05-30. Item 5.07 · say-on-pay result. As reported: 77.45% (votes for as printed: 286,771,841). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-06-03. Item 5.07 · say-on-pay result. As reported: 82.81% (votes for as printed: 318,678,236). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 417,500 + equity 1,110,006 + all other 0 = 1,527,506, summed across the director compensation table rows.
- GoodRx Holdings, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-29. CEO total compensation as printed in GoodRx Holdings, Inc.'s own proxy. As printed: 23,367,483. View filing ↗
- Doximity, Inc., Section 10b CEO total. DEF 14A, filed 2026-07-15. CEO total compensation as printed in Doximity, Inc.'s own proxy. As printed: 19,586,169. View filing ↗
- DaVita Inc., Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in DaVita Inc.'s own proxy. As printed: 18,210,597. View filing ↗
- Quest Diagnostics, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in Quest Diagnostics, Inc.'s own proxy. As printed: 15,498,479. View filing ↗
- Astrana Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-17. CEO total compensation as printed in Astrana Health, Inc.'s own proxy. As printed: 14,930,231. View filing ↗
- Evolent Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Evolent Health, Inc.'s own proxy. As printed: 14,240,154. View filing ↗
- R1 RCM Inc., Section 10b CEO total. DEF 14A, filed 2024-04-12. CEO total compensation as printed in R1 RCM Inc.'s own proxy. As printed: 14,159,376. View filing ↗
- HealthEquity, Inc., Section 10b CEO total. DEF 14A, filed 2026-05-13. CEO total compensation as printed in HealthEquity, Inc.'s own proxy. As printed: 13,582,105. View filing ↗
- Alignment Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Alignment Healthcare, Inc.'s own proxy. As printed: 11,278,583. View filing ↗
- Teladoc Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Teladoc Health, Inc.'s own proxy. As printed: 11,202,996. View filing ↗
- Privia Health Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Privia Health Group, Inc.'s own proxy. As printed: 10,472,698. View filing ↗
- Guardant Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Guardant Health, Inc.'s own proxy. As printed: 8,661,227. View filing ↗
- Progyny, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in Progyny, Inc.'s own proxy. As printed: 7,220,612. View filing ↗
- LifeStance Health Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in LifeStance Health Group, Inc.'s own proxy. As printed: 6,645,380. View filing ↗
- Certara, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-03. CEO total compensation as printed in Certara, Inc.'s own proxy. As printed: 6,491,387. View filing ↗
- agilon health (subject), Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in agilon health's own proxy. As printed: 5,610,878. View filing ↗
- Veeva Systems, Inc., Section 10b CEO total. DEF 14A, filed 2026-05-04. CEO total compensation as printed in Veeva Systems, Inc.'s own proxy. As printed: 470,833. View filing ↗
- Section 10a, DaVita Inc. reciprocity. DEF 14A. DaVita Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. View filing ↗
- Section 10a, Doximity, Inc. reciprocity. DEF 14A. Doximity, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. View filing ↗
- Section 10a, Evolent Health, Inc. reciprocity. DEF 14A. Evolent Health, Inc. names agilon health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, R1 RCM Inc. reciprocity. DEF 14A. R1 RCM Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. View filing ↗
- Section 10a, Progyny, Inc. reciprocity. DEF 14A. Progyny, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. View filing ↗
- Section 10a, Alignment Healthcare, Inc. reciprocity. DEF 14A. Alignment Healthcare, Inc. names agilon health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Privia Health Group, Inc. reciprocity. DEF 14A. Privia Health Group, Inc. names agilon health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Certara, Inc. reciprocity. DEF 14A. Certara, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. View filing ↗
- Section 10a, GoodRx Holdings, Inc. reciprocity. DEF 14A. GoodRx Holdings, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. View filing ↗
- Section 10a, Guardant Health, Inc. reciprocity. DEF 14A. Guardant Health, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. View filing ↗
- Section 10a, HealthEquity, Inc. reciprocity. DEF 14A. HealthEquity, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. View filing ↗
- Section 10a, LifeStance Health Group, Inc. reciprocity. DEF 14A. LifeStance Health Group, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. View filing ↗
- Section 10a, Quest Diagnostics, Inc. reciprocity. DEF 14A. Quest Diagnostics, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. View filing ↗
- Section 10a, Teladoc Health, Inc. reciprocity. DEF 14A. Teladoc Health, Inc. names agilon health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Veeva Systems, Inc. reciprocity. DEF 14A. Veeva Systems, Inc.'s most recent proxy was read; its disclosed peer group does not include agilon health. View filing ↗